| Клиническая онкология

Subscapular artery system flaps in head and neck reconstructive surgery: literature review and clinical experience
Authors: Fokin H.H. Kravets O.V. Т. 15, №1 (57)

Urachal carcinoma in the practice of a surgical oncologist: a clinical case series
Authors: Antoniv R.R. Pysar A.M. Т. 15, №1 (57)

Side effects of iodine-negative thyroid cancer targeted therapy
Authors: Solodyannikova O.I. Bankovska N.V. Danylenko V.V. Turitsyna V.L. Т. 15, №1 (57)

Pembrolizumab+chemotherapy versus atezolizumab+chemotherapy+/−bevacizumab for the first-line treatment of non-squamous NSCLC: a matching-adjusted indirect comparison
Т. 15, №1 (57)

Pembrolizumab plus chemotherapy for metastatic NSCLC with programmed cell death ligand 1 tumor proportion score <1%: pooled analysis of outcomes after five years of follow-up
Т. 15, №1 (57)

Thromboprophylaxis with original enoxaparin in oncology patients
Т. 15, №1 (57)

Inferior vena cava resection and reconstruction with falciform ligament graft for leiomyosarcoma. Case report
Authors: Kvasivka O.O. Moiseienko A.B. Pareniuk R.Y. Pepenin I.O.... Т. 15, №1 (57)

Reconstruction of the mandible using CAD/CAM technologies in patients with oral cancer and primary bone tumors
Author:Burtyn O.V. Т. 15, №1 (57)

CLL in the context of evidence-based medicine: how do international guidelines align with Ukrainian practice?
Authors: Kryachok I.A. Tytorenko I.B. Moroz Y.V. Т. 14, №4 (56)

Midazolam in modern anesthesiology and intensive care
Authors: Lisnyy I.I. Zakalska K.A. Т. 14, №4 (56)

Conducting mobilization courses and apheresis of CD34⁺. Experience of the Nonprofit Organization National Cancer Institute
Authors: Kryachok I.A. Raіnyk K.P. Shokun N.V. Burtna A.S. Т. 14, №4 (56)

Pembrolizumab vs Placebo as Adjuvant Therapy for High-Risk Stage II Melanoma: Long-Term Follow-Up, Rechallenge, and Crossover in KEYNOTE-716
Т. 14, №4 (56)

Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial
Т. 14, №4 (56)

KEYNOTE-006 study: results of 10-year follow-up of pembrolizumab versus ipilimumab in advanced melanoma
Т. 14, №4 (56)

A Multidisciplinary Approach to Breast Cancer Treatment in Historical Perspective
Т. 14, №4 (56)


Log in Registration Search for: Home Electronic publication Fresh number Archives Authors About Edition Subscription Requirements for authors Reviewing Editorial board
Organization of anticancer fight Tumors of the chest cavity Tumors of abdominal organs Tumors of skin, soft tissues, bones Breast tumor Oncogynecology Tumors of the head and neck Oncurology Oncohematology Radiation diagnostics, radiation therapy Experimental studies Magazine online All news	Subscapular artery system flaps in head and neck reconstructive surgery: literature review and clinical experience Authors: Fokin H.H. Kravets O.V. Т. 15, №1 (57) Urachal carcinoma in the practice of a surgical oncologist: a clinical case series Authors: Antoniv R.R. Pysar A.M. Т. 15, №1 (57) Side effects of iodine-negative thyroid cancer targeted therapy Authors: Solodyannikova O.I. Bankovska N.V. Danylenko V.V. Turitsyna V.L. Т. 15, №1 (57) Pembrolizumab+chemotherapy versus atezolizumab+chemotherapy+/−bevacizumab for the first-line treatment of non-squamous NSCLC: a matching-adjusted indirect comparison Т. 15, №1 (57) Pembrolizumab plus chemotherapy for metastatic NSCLC with programmed cell death ligand 1 tumor proportion score <1%: pooled analysis of outcomes after five years of follow-up Т. 15, №1 (57) Thromboprophylaxis with original enoxaparin in oncology patients Т. 15, №1 (57) Inferior vena cava resection and reconstruction with falciform ligament graft for leiomyosarcoma. Case report Authors: Kvasivka O.O. Moiseienko A.B. Pareniuk R.Y. Pepenin I.O.... Т. 15, №1 (57) Reconstruction of the mandible using CAD/CAM technologies in patients with oral cancer and primary bone tumors Author:Burtyn O.V. Т. 15, №1 (57) CLL in the context of evidence-based medicine: how do international guidelines align with Ukrainian practice? Authors: Kryachok I.A. Tytorenko I.B. Moroz Y.V. Т. 14, №4 (56) Midazolam in modern anesthesiology and intensive care Authors: Lisnyy I.I. Zakalska K.A. Т. 14, №4 (56) Conducting mobilization courses and apheresis of CD34⁺. Experience of the Nonprofit Organization National Cancer Institute Authors: Kryachok I.A. Raіnyk K.P. Shokun N.V. Burtna A.S. Т. 14, №4 (56) Pembrolizumab vs Placebo as Adjuvant Therapy for High-Risk Stage II Melanoma: Long-Term Follow-Up, Rechallenge, and Crossover in KEYNOTE-716 Т. 14, №4 (56) Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial Т. 14, №4 (56) KEYNOTE-006 study: results of 10-year follow-up of pembrolizumab versus ipilimumab in advanced melanoma Т. 14, №4 (56) A Multidisciplinary Approach to Breast Cancer Treatment in Historical Perspective Т. 14, №4 (56) 12 3 4 5...10 20...»Последняя »
MORION Publishing House Editorial office and publisher: 02140, Kyiv, ave. Bazhana 10A Tel.: 380 (44) 585-97-10 Specialized medical online publication for doctors, pharmacists, pharmacists, medical students and pharmaceutical universities.Disclaimer morion.ua apteka.ua pharmstandart.com.ua compendium.com.ua proximaresearch.com

Magazine online